EUVIMEDEUVIMED entdecken
Crossref

PRO: Systemic Therapy for All Endometrial Cancers Should be Paclitaxel Plus Carboplatin

Matthew A. Powell

Clinical Ovarian Cancer · 2011

DOI: 10.1016/j.cloc.2012.02.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Ovarian Cancer, 2011. Verfasst von Matthew A. Powell. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Powell, M. A. (2011). PRO: Systemic Therapy for All Endometrial Cancers Should be Paclitaxel Plus Carboplatin. Clinical Ovarian Cancer. https://doi.org/10.1016/j.cloc.2012.02.016

Vancouver

Powell MA. PRO: Systemic Therapy for All Endometrial Cancers Should be Paclitaxel Plus Carboplatin. Clinical Ovarian Cancer. 2011. doi:10.1016/j.cloc.2012.02.016

BibTeX
@article{Powell2011,
  author = {Powell, Matthew A.},
  title = {PRO: Systemic Therapy for All Endometrial Cancers Should be Paclitaxel Plus Carboplatin},
  journal = {Clinical Ovarian Cancer},
  year = {2011},
  doi = {10.1016/j.cloc.2012.02.016}
}
Kostenlos starten →